NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
Back to search
Official data from USPTO
GENESISCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENESISCARE
ST13
US500000079241451Class
36, 41, 42, 44
Filing
79241451
Registration
5876298
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/03/2026
Trademark type
Word
Nice classes
36, 41, 42, 44
Filing date
07/25/2018
Registration date
10/08/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/12/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Waterlooville, Hampshire, GB
Examiner
STINSON, JENNIFER ELLE
Current location
Historical data usage
Holders and representatives
Holders
Genesis Specialist Care Holding UK Limited
Representatives
Andrew S. Ehard Merchant & Gould P.C.
Technical classification
Nice Classes
Class 36Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable foundation servicesproviding financial assistance to organisationsprogramsservices of others for medical and healthcare research and to individuals of need for healthcare and the treatment of medical conditionsall the forgoing for the diagnosis and treatment of cancer and cardiac conditions; providing charitable fund raising activities the funds of which are to be used for providing financial assistance for organisationsprogramsservices of others for medical and healthcare research and to individuals of need for healthcare and the treatment of medical conditionsall the foregoing for the diagnosis and treatment of cancer and cardiac conditions
Class 41
Providing continuing medical education courses and medical training services in the field of cancer and cardiac care
Class 42
Medical research in the field of cancer and cardiac care
Class 44
Medical servicesmedical advisoryexamination and treatment servicesmedical analysis services for the diagnosis of cancermedical diagnostic services in the nature of testing and analysis for the diagnosis of cancermedical care services and medical clinics specializing in the diagnosis and treatment of cancer and cardiac conditions ; medical information and consultancy services; all the foregoing in the field of cancer and cardiac conditions
Publications
History of USPTO decisions and trademark events.
41 publications found
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/12/2026
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
02/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/09/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
10/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/21/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/01/2020
FIMP
FINAL DISPOSITION PROCESSED
02/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/17/2019
NPUB
NOTICE OF PUBLICATION
07/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/19/2019
CNEA
EXAMINERS AMENDMENT MAILED
06/19/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/18/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/18/2019
CNFR
FINAL REFUSAL MAILED
06/18/2019
CNFR
FINAL REFUSAL WRITTEN
06/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/20/2019
ALIE
ASSIGNED TO LIE
05/16/2019
ALIE
ASSIGNED TO LIE
05/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/30/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2019
RFNT
REFUSAL PROCESSED BY IB
01/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/14/2018
RFRR
REFUSAL PROCESSED BY MPU
12/14/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/30/2018
CNRT
NON-FINAL ACTION WRITTEN
11/29/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
11/28/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/14/2018
CNRT
NON-FINAL ACTION WRITTEN
11/13/2018
DOCK
ASSIGNED TO EXAMINER
11/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/27/2018
Continuous trademark protection
Get notified about every new filing that threatens GENESISCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.